Chemed (CHE) Accumulated Expenses (2009 - 2026)

Chemed's Accumulated Expenses history runs 18 years deep, the most recent figure standing at $62.8 million for Q1 2026.

• In Q1 2026, Accumulated Expenses rose 4.75% year-over-year to $62.8 million; the TTM figure through Mar 2026 stood at $62.8 million (up 4.75% YoY), while the FY2025 annual figure was $58.3 million, down 36.65% from the prior year.
• Accumulated Expenses was $62.8 million for Q1 2026 at Chemed, up from $58.3 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $92.1 million in Q4 2024 to a low of $49.8 million in Q1 2024.
• Historically, Accumulated Expenses has averaged $69.5 million across 5 years, with a median of $68.3 million in 2022.
• Biggest YoY gain for Accumulated Expenses was 20.29% in 2025; the steepest drop was 36.65% in 2025.
• A 5-year view of Accumulated Expenses shows it stood at $87.4 million in 2022, then gained by 1.18% to $88.4 million in 2023, then climbed by 4.18% to $92.1 million in 2024, then plunged by 36.65% to $58.3 million in 2025, then gained by 7.58% to $62.8 million in 2026.
• The last three Accumulated Expenses figures came in at $62.8 million (Q1 2026), $58.3 million (Q4 2025), and $79.7 million (Q3 2025), per Business Quant data.